• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环中 vaspin 水平与代谢相关脂肪性肝病患者的相关性:系统评价和荟萃分析。

Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis.

机构信息

The First Clinical Medical College of Zhejiang Chinese Medical University, No 548, Binwen Road, Hangzhou, 310051, Zhejiang Province, China.

The Second Clinical Medical College of Zhejiang Chinese Medical University, No 548, Binwen Road, Hangzhou, 310051, Zhejiang Province, China.

出版信息

Lipids Health Dis. 2022 Jul 2;21(1):57. doi: 10.1186/s12944-022-01658-2.

DOI:10.1186/s12944-022-01658-2
PMID:35780150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9250748/
Abstract

BACKGROUND

The incidence rate of metabolic-associated fatty liver disease (MAFLD) is increasing annually; however, there are still no effective methods for establishing an early diagnosis and conducting real-time tracing. Vaspin can affect the metabolic processes in the body, and it is closely associated with many metabolic diseases. Many previous studies have speculated on the association between vaspin and MAFLD, but the results of these studies have not been conclusive. This meta-analysis examined the differences in circulating vaspin levels between patients with MAFLD and healthy individuals.

METHODS

Six databases and other sources were searched with free terms and Medical Subject Headings terms, and a total of 13 articles were included (900 cases and 669 controls). RevMan 5.3 and Stata 16 were used for analysis. The standardised mean difference (SMD) and 95% confidence interval (CI) were used to assess the overall outcomes. Cohen's kappa coefficient was applied to examine the differences between the two authors in the selection of studies and in the evaluation of the quality of evidence for the studies.

RESULTS

The results demonstrated that there was no significant difference in the circulating vaspin levels between the MAFLD group and healthy group (SMD = 0.46, 95% CI: [- 0.12, 1.04]). The subgroup analysis suggested that area and body mass index (BMI) may be the sources of heterogeneity, and the results of univariate meta-regression analysis were consistent with those of the subgroup analysis (P = 0.005 and P < 0.001, respectively). Furthermore, BMI may better explain the source of heterogeneity (P = 0.032) in the multivariate meta-regression analysis.

CONCLUSION

In summary, no significant correlation was observed between the circulating vaspin levels and MAFLD. BMI may be an important factor affecting this correlation, which may provide a reference for further studies on mechanism and diagnosis of MAFLD.

摘要

背景

代谢相关脂肪性肝病(MAFLD)的发病率逐年上升,但目前仍缺乏有效的早期诊断和实时追踪方法。内脏脂肪素(vaspin)可影响机体的代谢过程,与多种代谢性疾病密切相关。许多既往研究推测了内脏脂肪素与 MAFLD 之间的相关性,但这些研究的结果并不一致。本荟萃分析旨在探讨 MAFLD 患者与健康人群循环内脏脂肪素水平的差异。

方法

通过自由词和医学主题词检索了 6 个数据库和其他来源,共纳入 13 项研究(900 例患者和 669 例对照)。采用 RevMan 5.3 和 Stata 16 进行分析。采用标准化均数差(SMD)及其 95%置信区间(CI)评估汇总结果。应用 Cohen's kappa 系数评估两位作者在研究选择和证据质量评估方面的差异。

结果

结果显示,MAFLD 组与健康组的循环内脏脂肪素水平无显著差异(SMD=0.46,95%CI:-0.12,1.04)。亚组分析提示,研究地区和体质量指数(BMI)可能是异质性的来源,单变量meta 回归分析结果与亚组分析结果一致(P=0.005 和 P<0.001)。进一步的多变量meta 回归分析表明,BMI 可能更好地解释了异质性的来源(P=0.032)。

结论

综上所述,循环内脏脂肪素水平与 MAFLD 之间无显著相关性。BMI 可能是影响这一相关性的重要因素,这可能为 MAFLD 机制和诊断的进一步研究提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/b15d31ef9e98/12944_2022_1658_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/c3d7086c6e93/12944_2022_1658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/51908d685d4d/12944_2022_1658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/ae03112f433b/12944_2022_1658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/d41f36ced259/12944_2022_1658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/244d27b84e9c/12944_2022_1658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/0234da8f8912/12944_2022_1658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/465529e0f73a/12944_2022_1658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/faaf749ae930/12944_2022_1658_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/a1f6b8e689a9/12944_2022_1658_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/80ce2a044a73/12944_2022_1658_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/b15d31ef9e98/12944_2022_1658_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/c3d7086c6e93/12944_2022_1658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/51908d685d4d/12944_2022_1658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/ae03112f433b/12944_2022_1658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/d41f36ced259/12944_2022_1658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/244d27b84e9c/12944_2022_1658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/0234da8f8912/12944_2022_1658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/465529e0f73a/12944_2022_1658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/faaf749ae930/12944_2022_1658_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/a1f6b8e689a9/12944_2022_1658_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/80ce2a044a73/12944_2022_1658_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/9250748/b15d31ef9e98/12944_2022_1658_Fig11_HTML.jpg

相似文献

1
Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis.循环中 vaspin 水平与代谢相关脂肪性肝病患者的相关性:系统评价和荟萃分析。
Lipids Health Dis. 2022 Jul 2;21(1):57. doi: 10.1186/s12944-022-01658-2.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Omega-3 fatty acids for depression in adults.ω-3 脂肪酸治疗成人抑郁症。
Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5.
8
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

引用本文的文献

1
Adipokine and Hepatokines in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current and Developing Trends.代谢功能障碍相关脂肪性肝病(MASLD)中的脂肪因子和肝脏因子:现状与发展趋势
Biomedicines. 2025 Jul 30;13(8):1854. doi: 10.3390/biomedicines13081854.
2
Effect of adipokines on bone marrow mesenchymal stem cell function.脂肪因子对骨髓间充质干细胞功能的影响。
World J Stem Cells. 2025 May 26;17(5):106150. doi: 10.4252/wjsc.v17.i5.106150.

本文引用的文献

1
Recent Developments in NAFLD.非酒精性脂肪性肝病的最新进展。
Int J Mol Sci. 2022 Mar 7;23(5):2882. doi: 10.3390/ijms23052882.
2
Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.多囊卵巢综合征患者循环脂肪因子水平:系统评价和荟萃分析。
Reprod Sci. 2021 Nov;28(11):3032-3050. doi: 10.1007/s43032-021-00709-w. Epub 2021 Sep 1.
3
Review: Vaspin (SERPINA12) Expression and Function in Endocrine Cells.综述:内分秘细胞中 Vaspin(SERPINA12)的表达和功能。
Cells. 2021 Jul 6;10(7):1710. doi: 10.3390/cells10071710.
4
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.非酒精性脂肪性肝病、胰岛素抵抗、代谢综合征及其与血管风险的关系。
Metabolism. 2021 Jun;119:154770. doi: 10.1016/j.metabol.2021.154770. Epub 2021 Apr 14.
5
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.PRISMA 2020 解释和说明:系统评价报告的更新指南和范例。
BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160.
6
MAFLD: Now is the time to capitalize on the momentum.MAFLD:现在是利用这一势头的时候了。
J Hepatol. 2021 May;74(5):1262-1263. doi: 10.1016/j.jhep.2021.02.002. Epub 2021 Feb 12.
7
Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis.非肥胖多囊卵巢综合征女性与非肥胖对照女性循环脂肪因子水平:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Jan 7;11:537809. doi: 10.3389/fendo.2020.537809. eCollection 2020.
8
Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病患者循环鸢尾素水平:一项系统评价和荟萃分析
Gastroenterol Res Pract. 2020 Nov 7;2020:8818191. doi: 10.1155/2020/8818191. eCollection 2020.
9
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
10
Association of vaspin gene expression and its serum level on the risk of ischemic stroke in type 2 diabetic Egyptian patients: Prospective case-control study.2 型糖尿病埃及患者中 vaspin 基因表达及其血清水平与缺血性脑卒中风险的相关性:前瞻性病例对照研究。
Biotechnol Appl Biochem. 2020 Nov;67(6):912-919. doi: 10.1002/bab.1850. Epub 2020 Feb 4.